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In-room Magnetic Resonance Imaging (MRI) allows the acquisition of fast 2D cine-18 MRI centered in the tumor for advanced motion management in radiotherapy. To 19 achieve 3D information during treatment, patient-specific motion models can be 20 considered the most viable solution. However, conventional global motion models are 21 built using a single motion surrogate, independently from the anatomical location. 22
In this work, we present a novel motion model based on regions of interest (ROIs) 23 established on 4D Computed Tomography (4DCT) and 2D cine-MRI, aiming at 24 accurately compensating for changes during treatment. In the planning phase, a 25 motion model is built on a 4DCT dataset, through 3D deformable image registration 26 (DIR) . ROIs are then defined and correlated with motion fields derived by 2D DIR 27 between CT slices centered in the tumor. In the treatment phase, the model is applied 28 to in-room cine-MRI data to compensate for organ motion in a multi-modal framework, 29
aiming at estimating a time-resolved 3DCT. 30 The method is validated on a digital phantom and tested on two lung patients. Analysis 31 is performed by considering different anatomical planes (coronal, sagittal and a 32 combination of the two) and evaluating the performance of the method on tumor and 33 diaphragm. For the phantom study, the ROI-based model results in a uniform median 34 error on both diaphragm and tumor below 1.5mm. For what concerns patients, median 35 errors on both diaphragm and tumor are around 2mm (maximum patient resolution), 36 confirming the capability of the method to regionally compensate for motion. 37 A novel ROI-based motion model is proposed as an integral part of an envisioned 38 clinical MRI-guided workflow aiming at enhanced image guidance compared to 39 conventional strategies. 40 41 1. Introduction 42 In recent years, the advent of in-room Magnetic Resonance Imaging (MRI) systems 43
integrating MRI scanners with delivery units (i.e. MRI-linacs), paved the way to 44 innovative image-guided solutions in radiation therapy (Menard and van der Heide  45 2014, Paganelli et al. 2018) . Routine clinical application of such systems is expected 46 Switzerland  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 2 to reduce target localization errors, with improved target coverage and sparing of 47 surrounding healthy tissues (Jaffray 2012) . The treatment of mobile tumors, i.e. 48 lesions affected by respiratory motion, will especially benefit from these technologies, 49 which enables non-ionizing anatomical in-room imaging combined with advanced 50 motion management strategies (Keal et al. 2006b ; Colvill et al. 2016 ). 51
In current in-room MRI systems (Fallone 2014; ; Jaffray 2012; Langendijk 52 2014; Mutic 2014), the trade-off between acquisition time and image quality suggests 53 fast 2D cine-MRI centered in the tumor as the preferred imaging solution for motion 54 detection, thus providing internal anatomy information at a good temporal resolution. 55 Different solutions for gating (Park et al. 2016) (Seregni et al. 2018 ) methods are the most explored target referencing 60 strategies in the literature (Menten et al. 2017; Fast et al. 2017 ). However, the bi-61 dimensional information provided by the cine-MRI approach does not fully 62 characterize the 3D motion of the whole tumor, making it difficult to accurately 63 compensate for motion of irregularly shaped or deformable tumors. A practical 64 countermeasure is based on the MRI capability to allow image acquisition along 65 different orientations, thus enabling fast interleaved orthogonal cine-MRI slices 66
intersecting the target and reconstructing the 3D position of the tumor (Sawant et al. 67 2014; Bjerre et al. 2013 ). This however is limited to the local information centered in 68 the tumor. Another viable solution is therefore represented by patient-specific global 69 motion models, which relate in-room surrogates with time-resolved pre-treatment 70 imaging and enables reconstructing the whole 3D anatomy during treatment 71 (McClelland et al. 2013 ). This is particularly suitable for multi-target tracking problems, 72 such as lung cancer, where both the primary tumor and involved nodes need to be 73 simultaneously targeted, and for retrospective calculation of the accumulated dose in 74 both tumor and organs at risk (Kamerling et al. 2016 ). 75
Conventional global motion models for image-guided radiotherapy, are built on four-76 dimensional Computed Tomography (4DCT), being the current clinical standard of 77 time-resolved imaging for treatment planning (Keall 2004 ). These models rely on the 78 correlation of deformation vector fields derived from 3D DIR between 4DCT respiratory 79 phases with a mono-dimensional external surrogate. A recent study investigated the 80 performance of a motion model using external and internal surrogates. Better results 81
were achieved using lung volume as a surrogate, suggesting the use of internal 82 structures as the most advantageous solution (Wölfelschneider et al. 2017 ). 83
In the MRI-guidance scenario, 4DMRI scans can be acquired as pre-treatment images 84 both prospectively (Hu et al. 2013) A recent work investigated also the effect of inter and intra-fractional motion in kidney, 92
by means of an on-board (pre-beam) 4DMRI motion model and simulated pseudo CT 93 (Stemkens et al. 2017 ).
94
A potential limitation of these approaches for motion modeling relies on the 95 assumption of a correlation between the one-dimensional in-room motion and the 96 Page 2 of 24 AUTHOR SUBMITTED MANUSCRIPT -PMB-107261 .R3   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (2016) derived a weighting factor from a similarity metric  99  between pre-treatment images and 2D cine-MRI for the adaptation over the entire  100 anatomy. Additionally, none of these MRI-guided motion models were directly built nor 101 included information on a pre-treatment 4DCT, thus limiting potential clinical 102 applicability related to an optimized dosimetric plan directly defined on 4DCT. 103
In this work, we propose a novel global motion model aiming at accurately 104 compensating for motion of anatomo-pathological structures in the framework of lung 105 MRI-guided radiation therapy. The model is based on regions of interest (ROIs) to 106 differentiate between anatomical districts and, therefore, mitigate the effect of uneven 107 respiratory motion. This approach is put forward as part of an envisioned clinical 108 workflow where the potential of multi-modal imaging is exploited. Specifically, the 109 motion model is built on a planning 4DCT dataset and applied to in-room 2D cine-MRI 110
data. This could be potentially used in a clinical scenario to accurately account for 111 motion and perform dosimetric evaluations, relying on current standards for motion 112 management provided by the 4DCT dataset. 113
The proposed workflow was simulated with a digital CT/MRI lung phantom for 114 validation purposes. In addition, a preliminary application on two lung patients is 115
reported. 116 117
Material and Methods

118
In this section, we present an outline of the methodological solution developed for 119 the ROI-based motion model using planning 4DCT, pre-beam 3D T1-weighted MRI 120 and in-beam interleaved 2D sagittal and coronal cine-MRI data. The ROI-based 121 motion model allows the volumetric estimation of a time-resolved virtual 3DCT of the 122 internal patient configuration. The performance of the proposed approach is evaluated 123 on a dataset comprising synthetic and clinical data. 124 125 2.1. ROI-based motion model 126
The workflow of the method can be divided in two main steps: model construction 127
and model application. During the construction process, we derive a model which 128
couples the 3D motion, derived from 4DCT data, with 2D motion, derived from 2D CT 129 slices centred in the tumor. A principal component analysis (PCA) approach (Fayad et 130 al. 2012 ) is implemented for model creation on ROIs related to anatomical structures. 131
To assure 2D slice correspondence between planning and in-beam acquisition 132 needed for model application, a 3D rigid registration is performed between the 133 planning 3D CT and a pre-beam 3D MRI. The model is then applied relying on in-134 beam 2D motion information, derived by generating virtual 2D cine-CT images from 135 acquired 2D cine-MRI, in a multi-modal registration pipeline. This aims at estimating 136 the 3D anatomical deformation for each cine-MRI sample, deriving time-resolved 137 3DCT volumes. 138
The workflow of the proposed method is shown in Figure 1 . The model construction is performed as follows. 145 i.
3D DIR on planning 4DCT 146
Respiratory motion is described as 3D non-rigid transformation with respect to the 147 end-exhale reference volume, which is typically considered as the most stable 148 respiratory phase. Specifically, 3D DIR is performed between each 4DCT phase and 149 the reference exhale volume (3DCT-0%), to derive time-resolved 3D vector fields 150 (3DVFs) representing organ motion during respiration. The registration consists of a 151 3D multi-stage mono-modal B-spline registration. 152
ii.
Mono-modal 2D DIR 153
The model construction includes also the definition of respiratory motion information 154 derived from 2D planning images. This is based on 2DVFs computed by means of 2D 155 mono-modal DIR between orthogonal (coronal and sagittal) slices centred in the tumor 156 at different respiratory phases of the 4DCT (sliceCT). Again, the exhale is considered 157 as the reference for 2D DIR (sliceCT-0% Then a matrix is constructed as follows: 184
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Pre-beam 3D registration 195
A volumetric rigid registration between a pre-beam 3D MRI acquired at the exhale 196 (3DMRI-0%) and the planning 3DCT-0% is applied to achieve correspondence among 197
2D CT slices used during model construction and in-room acquisitions. This is 198
performed under the assumption that no deformation occurred between planning and 199 treatment, thus assuming a timely acquisition between CT and MRI data. This 200 procedure is furtherly justified for the patient study, as 3D MRI scans were acquired 201 under breath-hold condition, which does not represent the free-breathing exhale state 202 (additional details in 4.1). 203
In-beam multi-modal 2D DIR 204
Two stages of multi-modal 2D DIR are performed in this step (B-spline registration 205 with mutual information as similarity metric). 206
At first, DIR is applied between in-beam cine-MRI data and corresponding 3DMRI-0% 207 slices (sliceMRI-0%) selected through image alignment, to obtain a virtual T1-208 weighted cine-MRI (vcine-T1). Then, the resulting vcine-T1 is registered with 3DCT-209 0% corresponding slices (sliceCT-0%), generating a virtual cine-CT (vcine-CT). 210
The first stage is introduced to guarantee slice correspondence and to improve the 211 performance of 2D DIR between sliceCT-0% and cine-MRI, whereas the second 212 assures consistency between model construction (built on CT data) and model 213 application. 214
iii.
In-beam 2D motion definition 215
In-beam motion is defined by the selection of the maximum or minimum value of the 216 in-beam 2DVFs (defined on vcine-CT) within the tumor and diaphragm masks. Here, 217 differently from model construction, also minimum values of 2DVFs are taken into 218 account, in order to compensate for baseline drifts consisting in a deeper exhale of 219 the in-beam sample with respect to the reference sliceCT-0%. As such, by selecting 220 the maximum value, positive motion variations with respect to the sliceCT-0% are 221 compensated, whereas, by using the minimum, variations in the opposite direction can 222 be managed. To define when to use the maximum or minimum value, contours 223 delineated on the sliceCT-0% are warped on cine-MRI by applying the generated 224 2DVF: if the position of the warped contour is above the sliceCT-0% contour (deep-225 exhale), the minimum is selected; on the contrary (deep-inhale), the maximum is 226 considered. 227
iv. Time-resolved virtual 3DCT estimation 228
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To provide the estimated 3D deformation between the reference 3DCT-0% and the 229 patient state as seen on cine-MRI, in-beam 2D motion values are fed to the ROI-based 230 motion model for each ROI, as follows: 231 -in case of in-beam maximum value of the 2DVF 232
By merging the 3DVFs of the considered ROIs, a 3 is obtained describing the 236 whole anatomy deformation. The inverted 3 is finally applied to deform the 237 3DCT-0% through volume warping, deriving a virtual 3DCT for each cine-MRI sample. 238
The result is thus a time-resolved v3DCT. 239 240
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Comparisons were performed between the 3DCT-0% (or sliceCT-0%) and the output 291 of the registration for the mono-modal case, whereas the vcine-CT was compared with 292 the cine-MRI for the multi-modal case. Tumor and diaphragm contours were warped 293 accordingly and compared with the ground truth ones for DIR assessment. The metrics 294 considered for DIR evaluation were as follows: the normalized mutual information 295 (NMI) before and after registration on the upper and lower ROIs; the median distance 296 of the diaphragm profile and the distance of the tumor center-of- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 11 Additionally, the performance of the proposed method was tested against the use of 309 different anatomical planes during model construction and model application. Coronal 310 and sagittal slices were considered separately using RL/SI (e.g.
in ROI-based model) and AP/SI (e.g. 2 / 2 in ROI-based model) 312 components respectively. Also, a combination of two orientations was tested using the 313 mean value of the SI components for coronal/sagittal combination. 314
Given the availability of ground truth volumes provided by the phantom, a 315 quantitative volumetric analysis was possible between the estimated volumes and the 316 ground truth volumes. Specifically, the distance between the diaphragm profile and 317 the 3D distance of the tumor COM between time-resolved v3DCT and ground truth 318 volumes were adopted as metrics of local discrepancy; whereas NMI was considered 319
for a global evaluation in the upper and lower regions. The same quantifications were 320 also performed between the ground truth volumes and the outputs of the Fayad model. 321
A Friedman test (alpha=5%) was performed between error populations of diaphragm 322 distance and COM, to define significant differences. 323
Moreover, the regularity of the 3 was evaluated by quantifying the difference 324 of the estimated 3 with the one computed between the 3DCT-0% and the 325 ground truth volume. This difference was assessed on the whole volume and at the 326 interface (upper/lower ROIs) of the combined 3 . 327 328 2.4.2. Patient evaluation 329
The proposed method was tested on clinical data where no ground truth was 330 available. The analysis was therefore limited to 2D local comparison between in-room 331 measurement (i.e. cine-MRI) and the corresponding slices of the estimated v3DCT. 332
Specifically, tumor and diaphragm contours defined on the 3DCT-0% were warped on 333 the cine-MRI and on the v3DCT data and compared. Structures displacement was 334 evaluated in 2D along the available imaging plane. 335
A comparison with the Fayad model (supplementary material A) based on the sole 336 diaphragm/tumor motion trace was also performed, as for the phantom study. 337
Additionally, a 3D comparison was performed between the estimated volume and 338 the most similar respiratory phase in the 4DCT dataset, in order to account for 339 variations between treatment and planning. The phase correspondence was defined 340 by comparing cine-MRI and planning contours. NMI was calculated on the upper and 341 lower ROIs and its correlation with structures displacement was evaluated using the 342
Pearson's correlation coefficient (p-value = 5%). 343
For patient P2, the ROI-based motion model was applied on two different 344 anatomical planes (coronal and sagittal separately) as well as on their combination. 345
Only coronal plane was instead considered for patient P1, being the only one 346 available. 347
The computational cost was also assessed for each step of the proposed workflow. 348 349 3. Results 3.1. Registration performance 351 Table 3 shows the performance of the mono-modal and multi-modal DIR used as a 352
basis for the motion model construction during planning and subsequent in-beam 353 application. NMI values increased after the registration in most of the cases for both 354 the upper and lower regions. This was also accompanied by a median COM and 355 diaphragm distance in the order of the voxel resolution for both mono-modal and multi-356 modal registration in phantom and patients' data.
358
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Fayad-diaphragm and Fayad-tumor model; whereas for tumor errors, significant 376 differences were obtained between ROI-based and Fayad-diaphragm in the 377 sagittal/coronal combination. Figure 3 shows 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 13 The difference between the estimated VF (
3 ) and the one derived between 385
3DCT-0% and the ground truth volume (Figure 4 ) was in median 0.36 mm (IQR: 0.41 386 mm) for the whole volume and 0.29 mm (IQR: 0.54 mm) at the 3DVFs interface. 387
Maximum errors (excluding the heart) were within ±2mm. Errors lower than -2mm were 388 mainly quantified in the heart area (Figure 4b 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
405 406
Page 14 of 24 AUTHOR SUBMITTED MANUSCRIPT -PMB-107261 .R3   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t The ROI-based method performance on clinical data depending on the considered 414 anatomical plane is reported in Table 4 . For P1, errors within 2 mm were found by 415 considering the coronal slice only. For P2, the combination of coronal and sagittal 416 slices resulted in a lower median error on the diaphragm compared to single planes. 417
Errors above 2 mm were measured when considering the RL (coronal) direction, while 418 lower errors were found in the AP/SI direction for all the investigated anatomical 419 planes. The diaphragm profile and tumor COM trajectories as seen on cine-MRI and 420
v3DCT corresponding slices are shown in Figure 5 for patient P1 and P2. 421
A similar trend as in the phantom study was observed also for patients when 422
comparing the ROI-based motion model with the Fayad model based on the sole 423 diaphragm/tumor motion signal. Specifically, for P1, errors on diaphragm were <1mm 424 when using Fayad-diaphragm, but errors in SI of 2.10 mm (IQR: 2.97 mm) were 425 observed on the tumor compared to 1.16 mm (IQR: 0.99 mm) quantified for the ROI-426 based model. The ROI-based model provided also lower errors than Fayad-tumor (3.5 427 mm (IQR: 7.0 mm) / 2.53 mm (IQR: 3.28mm) on diaphragm/tumor for Fayad-tumor). 428
For P2, errors on diaphragm were comparable for ROI-based and Fayad model. Errors 429 on tumor were instead quantified below 1 mm in the coronal direction by the Fayad 430
model, but discrepancies up to 5 mm were found in the sagittal direction. 431
Regarding the difference between volumes of nearest phases in planning and 432 treatment, for P1, NMI median values were 1.23 (IQR: 0.01) and 1.21 (IQR: 0.03) for 433 upper and lower ROIs, respectively. Considering the combination of the two planes for 434 P2, NMI median values of 1.29 (IQR: 0.12) / 1.35 (IQR: 0.07) were measured on 435 upper/lower regions. A statistically significant correlation between distances of 436 Page 15 of 24 AUTHOR SUBMITTED MANUSCRIPT -PMB-107261 .R3   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 16 associated phases and NMI values was found for the ROI including the diaphragm 437 ( Figure 6a ). Conversely, a lower correlation was found for the upper region relevant to 438 tumor (Figure 6b) . A qualitative representation of the comparison between the 439 estimated v3DCT and the identified nearest 3DCT of the average respiratory cycle is 440 shown in Figure 6c . 441 442 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 modal registration took about 20s, whereas 3s and 40s were needed for 3DVF 467 estimation and CT reconstruction (inversion of the 3DVF included), respectively. 468
Measurements were carried out on a general-purpose machine equipped with Intel® 469
Xeon® processor (3.7 GHz) and 12GB RAM. 470 471 
Discussion
474
A novel ROI-based motion model was proposed, featuring regional adaptation and 475 estimation of in-room virtual CT volumes in an MRI-guided scenario for lung 476 Page 18 of 24 AUTHOR SUBMITTED MANUSCRIPT -PMB-107261 .R3   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 19 treatments. The method was validated on a digital CT/MRI phantom and then applied 477 to two lung patient cases. 478 479 4.1. ROI-based motion model 480
The first feature of the proposed model relies on the use of ROIs to account for 481 irregular and uncorrelated motion between different anatomical structures (e.g. tumor 482 motion vs. diaphragm motion). In the manuscript the method is presented considering 483 a partition of the whole anatomy in two ROIs. This decision was determined after a 484 preliminary analysis (supplementary materials B), which considered a different 485 number of ROIs. The analysis highlighted the better performance of using two ROIs 486 in the cranio-caudal direction (upper and lower region) that were described by specific 487
anatomical structures (i.e. derived from tumor and diaphragm contour masks), than 488
using different ROIs which do not rely on anatomical contours. 489
The accuracy of the mono-modal and multi-modal registration and the performance of 490 the model were addressed in both phantom and patient's data, attesting the capability 491 of the ROI-based model to accurately account for motion. As a result, an improved 492 description of the patient entire anatomy during treatment is potentially available. 493
Nonetheless, the considered ROIs were limited to regions described by tumor and 494 diaphragm motion. In the future we plan to integrate the information stemming from 495 other anatomical structures contoured on the planning 4DCT. 496
One limitation of the proposed model consists in reducing the information provided by 497 the 2DVFs to their maximum/minimum values. This was due to the current 498
implementation of the motion model, which reduced the motion information to their 499 principal components. Future developments will consider (i) deriving the most 500 informative subset of VF values rather than only maximum/minimum and (ii) improving 501 the motion model to account for the whole 2DVF. 502
A further improvement of the motion model could also be represented by combining 503
the ROIs definition with a separated description of the motion along the three 504 anatomical directions (i.e. RL, AP and SI). This will potentially mitigate the detrimental 505 effect of off-axis organ motion, as observed in patient P2 for the RL component. 506
Despite the limitations related to model construction, the proposed approach 507 presents an innovative feature in the estimation of time-resolved virtual 3DCT volumes 508 describing the patient anatomy during treatment. To our knowledge, this is the first 509 motion model directly built on 4DCT and cine-MRI data of the lung. Current 510 approaches rely on the acquisition of pre-beam 4DMRI and in-beam cine-MRI data of 511 kidney and liver, with dosimetric evaluation derived on simulated pseudo-CT 512 (Stemkens et al. 2017 ). On the contrary, the construction of our model within a multi-513 modal imaging pipeline including CT and MRI/cine-MRI data results in a CT-based 514 anatomical characterization and, as such, suitable for dosimetric evaluation. Although 515 the proposed approach is not currently implemented in real-time, it can be adopted 516 retrospectively within a standard clinical workflow. Its use would allow one to evaluate 517 the geometric accuracy of motion compensation strategies in current MRI-linac 518
systems. In addition, the dosimetric accuracy of the delivered dose could be directly 519 compared with the one planned on the 4DCT by means of dose accumulation, thus 520 potentially achieving a closed-loop adaptive radiotherapy workflow (Paganelli et al. 521 2018). 522
However, a limitation of the current workflow relies on not including inter-fraction 523 motion. Indeed, we assumed that no deformation occurred between 4DCT and MRI 524 acquisition. Currently, a rigid registration is performed between 3DCT-0% and 3DMRI-525 0% since patient data present a breath-hold 3DMRI, which is not representative of the 526 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 20 free-breathing condition of the 4DCT. Future developments aim at including a pre-527 beam free-breathing 3D or, ideally, a 4DMRI acquisition in the proposed workflow 528 (Stemkens et al. 2018 ). The availability of a 4DMRI will enable out-of-plane motion 529 detection, not recognizable in cine-MRI, as well as a better evaluation of inter-fraction 530 motion among respiratory phases. The inter-fraction motion can then be used to 531 update the model built on the 4DCT, as proposed in Fassi et al. (2015) . Despite this 532 limitation, our results are within the maximum voxel dimension, attesting that the model 533
is, at the current stage of development, able to compensate for motion. In addition, the 534 proposed method effectively manages breathing motion baseline drifts that may occur 535 during treatment. This is achieved by the selection of the maximum/minimum value of 536 the 2DVF, according to on-line variations with respect to the 0% planning phase. 537
Moreover, the 2D DIR between the cine-MRI and sliceMRI-0% was included as 538 supportive strategy for the multi-modal step. We also decided to include the T1-539
weighted MRI in the workflow since T1-weighted 4DMRI should be integrated into 540 commercial scanners in the near future (Winkelmann et al. 2007; Deng et al. 2016) . 541
This will allow to acquire a 4DMRI with reduced respiratory artefacts, which will be 542 included in the proposed workflow as pre-beam imaging. Finally, the method can be 543 easily extended to a fully MRI-guided treatment, where no 4DCT is acquired and the 544 model built on a 4DMRI. 545 546
4.2. Phantom study 547
For the phantom study, the ROI-based motion model performance was validated 548 and compared against a conventional strategy proposed in the literature (Fayad et al. 549 2012) relying on a single motion trace (e.g. tumor or diaphragm motion alone). 550
Although significant difference was not observed on the local tumor region, an 551 improved organ motion compensation on both tumor and diaphragm can be 552 appreciated. The conventional approach can mitigate errors effectively on the region 553 in which it acts but lower performance is observed on other anatomical structures as 554
shown by reported median errors (section 3.1). 555
In addition, as current MRI-linac systems feature both single (Mutic and Dempsey 556 2014) or interleaved (Langendijk et al. 2014) cine-MRI imaging capabilities, the 557 method reliability was tested against different anatomical planes: coronal, sagittal and 558 a combination of the two. Median errors below 1.45 mm were measured regardless 559 the adopted plane. However, interleaved sagittal/coronal cine-MRI acquisition is 560 expected to provide improved description of organ motion with respect to single plane 561
imaging. The phantom validation confirmed this assumption, as a better motion 562 description by the model was retrieved using interleaved cine-MRI images. 563
The availability of the phantom also allowed to compare the estimated motion field 564 with the ground truth deformation, in order to evaluate the combination of the different 565
VFs depending on the defined ROIs. Even if discontinuities were visible at the VFs 566 interface (Figure 4) , they do not affect image reconstruction, and maximum differences 567 with respect to the ground truth motion were within 2mm. Larger errors were visible in 568 the heart area mainly. This error does not have an impact on the performance of the 569 ROI-based model since such differences were quantified also for the Fayad model, 570
and a specific ROI defined on the heart could potentially mitigate it. Nevertheless, 571 further investigations will include regularization methods to avoid discontinuities in the 572 combination of VFs. 573 574
4
.3. Patient study 575
Page 20 of 24 AUTHOR SUBMITTED MANUSCRIPT -PMB-107261 .R3   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 21 For both lung patients, the ROI-based motion model was accurate in estimating 576 tumor and diaphragm position, especially in the SI direction. For patient P1, errors 577 below 2mm (i.e. maximum CT voxel resolution) were measured, attesting the ROI-578 based model capability to compensate for motion even when a single slice was 579 available. As regards patient P2, the cine-MRI field of view limited the analysis of 580 diaphragm motion to the coronal direction, where an error of 1.5mm for coronal/sagittal 581 combination was found. Similarly, median tumor errors were below 1.5mm for the SI 582
and AP component with the coronal/sagittal update planes. However, higher errors 583
were quantified in the RL direction, an effect probably due to the tumor proximity to 584 the heart which significantly affected motion. 585
Additionally, a 3D comparison was performed between the estimated volume and 586 the correspondent respiratory phase of the planning 4DCT data. Even if this could not 587 be considered a validation of the proposed approach, a correlation in the lower region 588 was observed between the global measure and discrepancies between the associated 589 respiratory phase, attesting that the model is producing physically sensible results. 590
The lack of a significant correlation in the upper region was probably due to a tighter 591 motion of the upper thorax with respect to the diaphragm motion. 592
Overall, the proposed method performed better than the conventional approach 593
implemented in Fayad et al. (2012) , showing its capability to account for motion 594 regionally. Although the method was tested on in-room samples which differed from 595 the planning condition, further investigations will be performed to evaluate the 596 capability of the motion model to account for more irregular breathing patterns, 597 baseline shifts as well as long term variations. A larger patient cohort is therefore 598 required for a more comprehensive evaluation. 599 600
Conclusion 601
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